New drug helps combat metabolic syndrome
In nonhuman trials, the drug has been shown to safely reduce plasma triglycerides and “bad” LDL cholesterol, and to reverse nonalcoholic fatty liver disease.
Source: Yale Science and Health News - Category: Universities & Medical Training Source Type: news